Retroviral-mediated overexpression of human bone morphogenetic protein 2 affects human mesenchymal stem cells during monolayer proliferation: A cautionary note
Background: Retroviral vectors are commonly used for gene transfer applications and they represent an effective way to provide a sustained delivery of a bioactive factor in basic research and tissue engineering applications. Cells that have been transduced with retroviral vectors ex vivo are usually...
Gespeichert in:
Veröffentlicht in: | Electronic Journal of Biotechnology 2014-07, Vol.16 (2) |
---|---|
Hauptverfasser: | , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Background: Retroviral vectors are commonly used for gene transfer
applications and they represent an effective way to provide a sustained
delivery of a bioactive factor in basic research and tissue engineering
applications. Cells that have been transduced with retroviral vectors
ex vivo are usually amplified on tissue culture plastic, for a
prolonged period of time, in order to obtain sufficient cell numbers
prior to the experiment of interest. However, the effect of the
transgene product on the transduced cells, during this period of time,
is rarely, if ever, investigated. The current study investigated if
transduction with a VSG.G pseudotyped retroviral vector expressing
human bone morphogenetic protein 2 (Rv.BMP-2) influences the gene
expression profile of human bone marrow-derived mesenchymal stem cells
(hMSCs) during monolayer proliferation. hMSCs that have been transduced
with a VSG.G pseudotyped retroviral vector expressing enhanced green
fluorescent protein (Rv.eGFP) served as controls. Results: It was
confirmed that Rv.BMP-2 transduced hMSCs produce detectable amounts of
bone morphogenetic protein 2 (BMP-2). Gene expression analysis revealed
that the hypertrophic marker collagen X was down-regulated by
approximately 50% and the chondrogenic marker Aggrecan was elevated
almost 9-fold in Rv.BMP-2 transduced hMSCs if compared to Rv.eGFP
transduced control cells. Interestingly, the same changes in gene
expression were detected when hMSCs were exposed to 100 ng/ml of
recombinant human BMP-2 and their gene expression profile was compared
to control hMSC. Again, collagen X message was down-regulated and
Aggrecan message was up-regulated. Conclusion: These results indicate
that, when using integrating vectors and then expanding the cells after
transduction, controls need to be carefully planned to ensure the
results obtained during the 3D experiments are not due to artefacts
created in response to the different cell proliferation conditions
employed. |
---|---|
ISSN: | 0717-3458 0717-3458 |